Incidence of thromboembolic events in testicular cancer patients receiving cisplatin (TESTCIS study)
Journal of Oncology Pharmacy Practice
Published online on April 29, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionDespite the increased incidence of testicular cancer in men aged 15 to 35, patients with this neoplasm have a high five-year survival rate thanks to chemotherapy. However, cisplatin, a drug used in the standard treatment for testicular cancer, ...
IntroductionDespite the increased incidence of testicular cancer in men aged 15 to 35, patients with this neoplasm have a high five-year survival rate thanks to chemotherapy. However, cisplatin, a drug used in the standard treatment for testicular cancer, ...